|

HRS-8080 Tablet Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 3: 1Phase 1/2: 1

Top Sponsors

  • Shandong Suncadia Medicine Co., Ltd.2

Indications

  • Breast Cancer2
  • Cancer2
  • Advanced Unresectable or Metastatic Breast Cancer of Adults1
  • Locally Advanced Breast Cancer1
  • Metastatic Breast Cancer1

Other2 trials

A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
Phase 3
A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.